According to the findings of a newly published study, the use of “THC is associated with a significant increase in survival time in ambulatory palliative patients”.
Conducted by researchers in Germany, the study titled The Use of Tetrahydrocannabinol Is Associated with an Increase in Survival Time in Palliative Cancer Patients: A Retrospective Multicenter Cohort Study was published in the peer-reviewed journal Medical Cannabis and Cannabinoids. The abstract is available online through the US National Library of Medicine.”
“Tetrahydrocannabinol (THC) is often prescribed for ambulatory palliative patients to improve sleep quality and appetite and to reduce anxiety, stress, and pain”, states the study. “However, it is not known if THC has also an effect on the mortality of these patients.”
Continue reading